or
forgot password

    • cancer clinical trials in des moines, IA

    • Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Mercy Medical Center - Des Moines

    Trial Locations
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
    Medical Oncology and Hematology Associates

    Trial Locations
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Capitol
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Medical Oncology and Hematology Associates

    Trial Locations
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Capitol
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
    Medical Oncology and Hematology Associates

    Trial Locations
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Capitol
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Gastrointestinal Stromal Tumor
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Medical Oncology and Hematology Associates

    Trial Locations
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Capitol
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
    Medical Oncology and Hematology Associates

    Trial Locations
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Capitol
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Iowa Lutheran Hospital

    Trial Locations
    Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Capitol
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
    Iowa Methodist Medical Center

    Trial Locations
    Iowa Methodist Medical Center
    Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center

    Trial Locations
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Breast Cancer, Lung Cancer, Metastatic Cancer, Pain, Prostate Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Iowa Methodist Medical Center

    Trial Locations
    Iowa Methodist Medical Center
    Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Capitol
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    John Stoddard Cancer Center at Iowa Methodist Medical Center

    Trial Locations
    John Stoddard Cancer Center at Iowa Methodist Medical Center
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Mercy Capitol Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Esophageal Cancer